by admin_63069 | Jul 3, 2024 | News You Can Use
“We hope this study encourages a national acceptance of active surveillance as an effective management strategy for prostate cancer,” says Daniel Lin, MD.
by admin_63069 | Jun 26, 2024 | News You Can Use
Study suggests it may even be detrimental in some groups of patients on active surveillance.
by admin_63069 | Jun 19, 2024 | News You Can Use
Highlights from the 2024 Prostate Cancer Academy
by admin_63069 | Jun 12, 2024 | News You Can Use
Treatment with Pluvicto following ARPI resulted in favorable progression and response outcomes in PSMA-positive mCRPR.
by admin_63069 | Jun 5, 2024 | News You Can Use
Stereotactic body radiotherapy and hormone treatment resulted in 40.1% 12-month progression-free survival in a recent study.
by admin_63069 | May 29, 2024 | News You Can Use
Hope for the future of prostate cancer treatment: the possibility of immune memory
